Medications/Clinical Trials in Fibromyalgia

REFERENCES

• Clark S, Tindall E, Bennett ' : A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol 12: 980–983, 1985.
   PubMed Web of Science ®Google Scholar
• Goldenberg DL, Felson DT, Dinerrnan H: A randomized, controlled trial of amitriptyline .16 naproxen in the treatment of patients with fibromyalgia. Arthri-tis Rheum 29: 1371–1377, 1986.
   Google Scholar
• Carette S, McCain GA, Bell DA, Fam AG: Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum 29: 655–659, 1986.
   PubMed Web of Science ®Google Scholar
• Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA: A comparison of cyclobenzaprine and placebo in the management of fibrosi-tis: A double-blind controlled study. Arthritis Rheum 31: 1535–1542, 1988.
   PubMed Web of Science ®Google Scholar
• Caruso I, Sarzi Puttini PC, Boccassini L, Santandrea S, Locati M, Volpato R, Montrone F, Benvenuti C, Beretta A: Double-blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome. J Jut Med Res 15: 154–159, 1987.
   Google Scholar
• Caruso I, Sarzi Puttini P,7zola M, Azzolini V: Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Jut Med Res 18: 201–209, 1990.
   Google Scholar
• Hench PK, Cohen R, Miller MM: Fibromyalgia: effects of amitriptyline, te-mazeparn, and placebo on pain and sleep. Arthritis Rheum 32 (Suppl 4): S47, 1989.
   Google Scholar
• Jaeschke R, Adachi JD, Guyatt G, Keller J, Wong B: Clinical usefulness of amitriptyline in fibromyalgia: The results of 23 N-of-1 randomized controlled trials. J Rheumatol 18: 447–451, 1991.
   PubMed Web of Science ®Google Scholar
• Quimby LG, Gratwick GM, Whitney CD, Block SR: A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol (Suppl 19): 140–143, 1989.
   PubMedGoogle Scholar
• Yunus MB, Masi AT, Aldag JC: Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheurnatol 16: 527–532, 1989.
   PubMed Web of Science ®Google Scholar
• Reynolds WJ, Moldofsky H, Saslcin P. Lue FA: The effects of cyclobenza-prine on sleep physiology and symptoms in patients with fibromyalgia. J Rheuma-tol 18: 452–454, 1991.
   PubMed Web of Science ®Google Scholar
• Russell U, Fletcher EM, Michalek JE, Mcbroom PC, Hester GG: Treat-ment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazo-lam-A double-blind, placebo-controlled study. Arthritis Rheum 34: 552–560, 1990.
   Google Scholar
• Jacobsen S, Danneskiold-Sainsoe B, Andersen RB: Oral S-adenosylme-thionine in primary fibromyalgia. Double blind clinical evaluation. Scand J Rheu-matol 20: 294–302, 1991.
   PubMed Web of Science ®Google Scholar
• Tavoni A, Vitali C, Bombardieri S. Pasero G: Evaluation of S-adenosylme-thionine in primary fibromyalgia. A double-blind crossover study. Am J Med 83: 107–110, 1987.
   Google Scholar
• Vaeroy H, Abrahainsen A, Forre O, Kass E: Treatment of fibromyalgia (fi-brositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo. Clin Rheumatol 8: 245–250, 1989.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P. Abeles M, Campbell SM, Clark P. Fam AG, F“SJ, FiechtnerJJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American Col-lege of Fibromatology 1990 Criteria for the Classification of Fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis 'u 33: 160–172, 1990.
   PubMed Web of Science ®Google Scholar
• Simms RW, Felson DT, Goldenberg DL: Development of Pre II u Cri-teria for Response to Treatment in Fibromyalgia Syndrome. J Rheumatol 18: 1558–63, 1991.
   PubMed Web of Science ®Google Scholar
• Carette S, Bell M, Reynolds J, Haraoui B, McCain G, Bujak V, Edworthy S, Baron M, Koehler B, Fam A, Bellamy N, Guimont C: A controlled trial of ami-triptyline, cyclobenzaprine, i. placebo in fibromyalgia. Arthritis Rheum 35 (Suppl): S112, 1992.
   Google Scholar